Neurodegeneration-Associated Microglia (NAM) <table class="infobox infobox-cell">
...
Neurodegeneration-Associated Microglia (NAM) <table class="infobox infobox-cell">
Introduction Neurodegeneration-Associated Microglia (NAM) are a specialized microglial phenotype identified through single-cell transcriptomics that emerges in response to chronic neurodegeneration. Unlike disease-associated microglia (DAM) or activated microglia, NAM represents a distinct cell state characterized by a specific gene expression signature associated with late-stage neurodegenerative processes[@kerenshaul2017].
Overview Microglia are the resident immune cells of the central nervous system, derived from yolk sac progenitors early in embryogenesis. In the healthy brain, microglia perform essential homeostatic functions including synaptic pruning, debris clearance, and immune surveillance.
Under neurodegenerative conditions, microglia adopt multiple activation states. The NAM phenotype represents one of these states, characterized by a gene expression profile distinct from both homeostatic microglia and the DAM response seen in early Alzheimer's disease.
<!-- taxonomy-enrichment -->
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
Morphology : neuron associated cell (source: Cell Ontology)Morphology can be inferred from Cell Ontology classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000095)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000095)
[OBO Foundry (CL:0000095)](http://purl.obolibrary.org/obo/CL_0000095)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000095)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000095)
[OBO Foundry (CL:0000095)](http://purl.obolibrary.org/obo/CL_0000095)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)
Molecular Signature
Marker Genes NAM cells are characterized by elevated expression of:
Distinguishing from DAM
Role in Neurodegeneration
Alzheimer's Disease NAM microglia are prominently found in:
Amyloid plaque vicinity - Surrounding dense-core plaquesTau pathology regions - Areas with neurofibrillary tanglesAtrophic regions - Areas showing neuronal loss
Pathogenic Functions
Failed phagocytosis - Impaired clearance of amyloid and debrisSynaptic loss - May contribute to synapse eliminationPro-inflammatory cytokine production - Chronic neuroinflammationIron accumulation - Ferrostatin-sensitive cell deathProtective Functions
Plaque containment - May limit amyloid spreadPhagocytic activity - Removal of dead cellsTrophic support - Limited neurotrophic factor releaseTREM2 and NAM Biology
TREM2 Variants TREM2 genetic variants significantly influence NAM function:
R47H (AD risk) - Impaired lipid sensing, reduced phagocytosisR62H - Intermediate riskQ33X (PLOSL) - Loss-of-function, Nasu-Hakola diseaseTREM2 Signaling Aβ/Lipid → TREM2 → TYROBP (DAP12) → SYK → PI3K → Phagocytosis
Therapeutic Targeting
Disease Associations
Alzheimer's Disease
NAM density correlates with cognitive decline
TREM2 variant carriers show altered NAM response
Appears in later disease stages
Parkinson's Disease
NAM-like cells in substantia nigra
Associated with α-synuclein pathology
May contribute to dopaminergic neuron loss
ALS
Upregulation of NAM markers in motor cortex
Linked to TDP-43 pathology
Microglial activation correlates with progression
Frontotemporal Dementia
NAM cells in affected cortical regions
Associated with tau and TDP-43 pathology
Therapeutic Implications
Modulating NAM Activity
TREM2 modulation - Agonists to enhance phagocytosisAnti-inflammatory approaches - Reduce chronic neuroinflammationLipid metabolism targeting - APOE-directed therapiesCSF1R inhibition - Reduce microglial proliferation
Biomarker Potential
TREM2 in CSF - Reflects microglial activationsTREM2 - Soluble TREM2 as disease markerNAM gene signature - Blood-based RNA signaturesResearch Methods
Identification
Single-nucleus RNA sequencing
Spatial transcriptomics
Flow cytometry with surface markers
Animal Models
5xFAD mice (amyloid model)
P301S tau model
α-synuclein overexpression models
TREM2 knock-in/knock-out crosses
See Also
[Microglia](/cell-types/microglia)
[TREM2](/genes/trem2)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Dementia with Lewy Bodies](/diseases/lewy-body-dementia)
[Neuroinflammation](/mechanisms/neuroinflammation-pathway)
Background The study of Neurodegeneration Associated Microglia (Nam) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/)
[AMP-AD Consortium](https://www.niagads.org/amp-ad)
[Allen Brain Atlas - Microglia](https://brain-map.org/)
Show full description